157 related articles for article (PubMed ID: 5005690)
1. The development of animal models for studies in Parkinson's disease.
Poirier LJ
Contemp Neurol Ser; 1971; 8():83-117. PubMed ID: 5005690
[No Abstract] [Full Text] [Related]
2. The striopallidal system: Its implication in motor disorders.
Poirier LJ; Parent A; Roberge AG
Pathobiol Annu; 1975; 5():339-67. PubMed ID: 812038
[No Abstract] [Full Text] [Related]
3. Parkinson's syndrome induced in cats by the use of 6-hydroxydopamine. Observations of behavior and motor disorders.
Mempel E; Wieczorek M
Acta Neurobiol Exp (Wars); 1990; 50(4-5):269-79. PubMed ID: 2130649
[TBL] [Abstract][Full Text] [Related]
4. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
5. Enriched environment induces cellular plasticity in the adult substantia nigra and improves motor behavior function in the 6-OHDA rat model of Parkinson's disease.
Steiner B; Winter C; Hosman K; Siebert E; Kempermann G; Petrus DS; Kupsch A
Exp Neurol; 2006 Jun; 199(2):291-300. PubMed ID: 16360152
[TBL] [Abstract][Full Text] [Related]
6. Parkinsonism: animal analogues of the human disorder.
Duvoisin RC
Res Publ Assoc Res Nerv Ment Dis; 1976; 55():293-303. PubMed ID: 826997
[No Abstract] [Full Text] [Related]
7. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.
Yuan H; Sarre S; Ebinger G; Michotte Y
J Neurosci Methods; 2005 May; 144(1):35-45. PubMed ID: 15848237
[TBL] [Abstract][Full Text] [Related]
8. Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease.
Ogura T; Ogata M; Akita H; Jitsuki S; Akiba L; Noda K; Hoka S; Saji M
Neurosci Res; 2005 Mar; 51(3):299-308. PubMed ID: 15710494
[TBL] [Abstract][Full Text] [Related]
9. Programmed cell death and Parkinson's disease.
Burke RE
Mov Disord; 1998; 13 Suppl 1():17-23. PubMed ID: 9613714
[No Abstract] [Full Text] [Related]
10. [Implications of the strio-nigro-striated ring in extrapyramidal function].
Poirier LJ
Mars Med; 1971; 108(3):177-82. PubMed ID: 4995915
[No Abstract] [Full Text] [Related]
11. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
[TBL] [Abstract][Full Text] [Related]
12. Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias).
Barbeau A
Neurotoxicology; 1984; 5(1):13-35. PubMed ID: 6538948
[TBL] [Abstract][Full Text] [Related]
13. [Dopaminergic conception of Parkinsonism and its treatment with L-DOPA].
Levin SL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(9):1418-26. PubMed ID: 4349303
[No Abstract] [Full Text] [Related]
14. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains.
Haobam R; Sindhu KM; Chandra G; Mohanakumar KP
Behav Brain Res; 2005 Sep; 163(2):159-67. PubMed ID: 15941598
[TBL] [Abstract][Full Text] [Related]
15. Dopamine and extrapyramidal motor function and dysfunction.
Hornykiewicz O
Res Publ Assoc Res Nerv Ment Dis; 1972; 50():390-415. PubMed ID: 4561070
[No Abstract] [Full Text] [Related]
16. Experimentally induced parkinsonism.
Poirier LJ; Sourkes TL
Res Publ Assoc Res Nerv Ment Dis; 1972; 50():416-33. PubMed ID: 4403656
[No Abstract] [Full Text] [Related]
17. Dopaminergic and cholinergic mechanisms in relation to postural tremor in the monkey and circling movements in the cat.
Poirier LJ; Langelier P; Bédard P; Boucher R; Larochelle L; Parent A; Roberge AG
Adv Neurol; 1974; 5():5-10. PubMed ID: 4216259
[No Abstract] [Full Text] [Related]
18. Estrogen and Parkinson's disease.
Horstink MW; Strijks E; Dluzen DE
Adv Neurol; 2003; 91():107-14. PubMed ID: 12442669
[No Abstract] [Full Text] [Related]
19. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P
Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice.
Richfield EK; Thiruchelvam MJ; Cory-Slechta DA; Wuertzer C; Gainetdinov RR; Caron MG; Di Monte DA; Federoff HJ
Exp Neurol; 2002 May; 175(1):35-48. PubMed ID: 12009758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
